Phibro animal health corp (PAHC)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13
OPERATING ACTIVITIES
Net income

36,712

38,060

40,914

54,713

68,030

73,021

65,305

64,883

58,142

61,945

68,330

64,615

64,457

59,391

76,152

82,728

77,912

76,031

60,101

60,280

32,234

21,908

9,962

-3,127

0

0

0

Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization

31,334

29,961

28,654

27,564

27,324

27,200

26,990

26,943

26,423

26,514

26,327

26,001

26,378

25,392

24,341

23,452

22,332

21,832

21,680

21,604

21,788

21,554

21,605

21,453

0

0

0

Amortization of debt issuance costs and debt discount

882

883

882

882

883

883

883

883

916

948

983

1,015

1,016

1,013

1,000

989

976

968

967

967

991

1,145

1,299

1,448

0

0

0

Stock-based compensation

2,259

2,259

2,259

2,259

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related costs of goods sold

0

0

0

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition-related accrued compensation

-

-

-

-

-

-

-

-

0

0

1,697

-

1,680

1,680

1,680

1,680

0

0

0

-

-

-

-

-

-

-

-

Acquisition-related accrued interest

0

0

0

-

-

-

0

-

0

0

1,233

-

1,707

1,642

1,524

1,476

0

0

0

-

-

-

-

-

-

-

-

Deferred income taxes

-3,126

-805

-284

-105

118

799

5,146

6,389

3,917

1,961

-964

-28

4,941

3,107

-20,576

-22,244

-21,687

-17,030

4,253

4,761

3,959

1,573

1,284

1,289

0

0

0

Foreign currency (gains) losses, net

933

2,043

-2,742

1,899

-362

634

3,961

635

1,356

1,149

619

867

2,888

4,642

2,194

7,725

4,424

5,120

8,494

3,376

1,608

-1,649

-1,286

-1,429

0

0

0

Other

-1,122

-1,143

452

302

344

308

-1,234

-1,181

-940

-873

-891

-765

-614

-515

-388

-354

-387

-231

-211

-61

204

368

597

538

0

0

0

Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable, net

1,746

1,867

9,529

23,679

30,120

15,731

3,599

11,900

12,489

6,257

15,057

2,765

-3,490

7,784

3,583

13,086

1,554

5,322

8,892

1,877

12,793

13,743

18,087

14,683

0

0

0

Inventories, net

927

1,292

20,564

20,982

16,034

29,725

28,600

24,292

20,168

12,430

4,308

-5,432

-7,254

-3,372

6,426

16,439

32,443

22,867

17,324

19,354

6,117

9,996

9,120

3,186

0

0

0

Other current assets

4,903

5,857

4,332

7,173

2,210

-1,269

-938

-134

2,180

8,682

5,040

3,012

1,151

-1,685

403

-457

-4,976

-2,550

-2,374

-7,416

-2,586

-4,950

-6,090

31

0

0

0

Other assets

1,521

2,560

1,741

299

372

-50

113

152

975

328

1,518

1,504

5,233

3,716

5,757

6,547

6,111

7,680

4,712

4,236

-6,628

-5,361

-5,178

-5,103

0

0

0

Accounts payable

3,558

-7,185

-2,536

12,092

37

142

1,588

2,446

10,053

9,021

5,537

-3,119

2,082

-3,070

-5,239

-3,245

-5,720

1,953

-3,646

4,796

-2,269

-2,776

12,242

1,682

0

0

0

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,813

0

0

0

Accrued expenses and other liabilities

7,159

7,945

5,973

4,098

-7,661

-9,686

-3,194

-114

4,596

9,245

663

5,471

4,388

-3,506

-2,405

-7,198

-6,898

110

307

-3,698

-11,803

-11,803

-12,606

-3,304

0

0

0

Net cash provided (used) by operating activities

70,350

59,054

42,319

47,169

42,399

49,551

66,485

70,008

73,474

87,745

81,732

98,385

111,402

79,347

61,068

37,218

32,488

48,545

48,950

68,704

29,500

8,655

16,870

-712

0

0

0

Capital expenditures

34,086

33,889

31,517

29,891

25,303

21,814

19,599

18,548

18,522

19,167

19,967

20,880

23,081

29,263

34,169

36,352

35,603

29,983

24,177

20,058

18,701

17,809

19,599

19,846

0

0

0

Business acquisitions

54,549

54,549

54,560

9,838

9,838

9,838

13,276

15,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other, net

1,479

1,476

438

404

-244

321

1,054

1,064

843

1,577

1,359

1,062

1,796

327

84

-137

-115

4,575

3,798

4,029

3,678

-1,234

-448

-434

0

0

0

Net cash provided (used) by investing activities

-96,114

-89,914

-60,515

-14,133

-38,897

-53,973

-83,929

-84,612

-79,365

-62,744

-32,888

-21,942

-24,907

-76,166

-80,829

-82,791

-87,411

-44,935

-38,352

-34,464

-27,379

-16,575

-19,151

-19,412

0

0

0

Revolving credit facility borrowings

250,000

265,000

261,000

213,000

216,130

218,130

234,130

225,000

277,870

267,370

258,370

230,500

151,500

228,000

234,000

255,500

0

0

0

-

-

-

-

175,500

0

0

0

Revolving credit facility repayments

200,000

204,000

178,000

187,000

185,630

201,130

234,130

220,000

242,370

244,870

235,370

234,500

203,500

199,500

192,500

189,500

0

0

0

-

-

-

-

209,500

0

0

0

Payments of long-term debt and other

12,667

12,647

12,649

12,649

-7,922

-3,194

1,534

6,401

286,844

285,987

286,450

285,527

4,233

4,239

3,924

3,929

3,930

4,952

3,963

4,090

336,692

335,800

336,218

335,374

0

0

0

Issuance of acquisition note payable

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from common shares issued

-

-

-

1,134

1,541

2,340

2,424

5,699

0

0

0

-

-

-

-

4,017

0

0

0

-

-

-

-

-

-

-

-

Dividends paid

19,417

19,418

19,409

18,592

17,774

16,948

16,121

16,073

16,023

15,953

15,875

15,827

15,782

15,763

15,739

15,708

15,670

15,631

15,609

15,595

0

0

0

-

-

-

-

Net cash provided (used) by financing activities

17,952

25,949

48,090

-4,107

3,181

-3,357

-17,886

-11,775

-13,039

-24,234

-24,223

-53,738

-69,383

10,547

25,161

50,380

67,083

2,671

2,955

-15,351

8,885

-1,280

-13,961

4,779

0

0

0

Effect of exchange rate changes on cash

-1,316

-245

-861

-524

-1,360

-1,070

-907

-536

173

198

61

-227

-27

120

198

-418

-739

-1,598

-1,485

-1,494

-1,181

-585

-860

-203

0

0

0

Net increase (decrease) in cash and cash equivalents

-9,128

-5,156

29,033

28,405

5,323

-8,849

-36,237

-26,915

-18,757

965

24,682

22,478

17,085

13,848

5,598

4,389

11,421

4,683

12,068

17,395

9,825

-9,785

-17,102

-15,548

0

0

0

Non-cash investing and financing activities
Capital/leasehold improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0